Benefits Of Attending

Why Attend Predictive Toxicology this Year?

1. Brand new focus day dedicated to assessing exactly how robust, reliable and predictive stem cells are and how to implement them as part of your predictive toxicology strategy.

2. DSEC panel discussion: get your questions answered and explore how to reduce the risks when implementing novel technologies with Bayer Healthcare, AstraZeneca and UCB Pharma

3. 19 + speakers new for this year: hear a range of novel approaches and case studies to ensure you are employing the most cutting edge approaches as part of an effective and accurate safety assessment strategy

Who Will Attend?

TOP TITLES:

  • Division Dir Genetic and Predictive Toxicology
  • Associate Director of Drug Safety
  • Genetic Toxicologist Senior Scientist
  • Principle Scientist Tox
  • Vice President Drug Metabolism Pharmacokinetics, Toxicology
  • Toxicology Scientist
  • Head of Genetic Tox Department
  • Director Special Toxicology
  • Head Business Development
  • Head of Medicinal Chemistry
  • Professor of Predictive Tox
  • Director of Center for Risk

TOP GEO:

  • United Kingdom
  • Denmark
  • France
  • Germany
  • Spain
  • Canada
  • Finland
  • Switzerland
  • The Netherlands
  • United States

What Your Peers think of the Past Predictive Toxicology Events:

…at the Predictive Toxicology Conference 2010, the aim is to provide attendees with practical knowledge which translates to better patient outcomes and better returns on investment
Dr Mitchell Friedman- Director of Toxicology, Takeda Pharmaceuticals (2010)
Late stage attrition of nascent drugs causes substantial losses, both financially and in terms of effort...Recent advances on several fronts are providing in silico, cellular and animal models that more faithfully predict clinical reality. I am speaking at Predictive Toxicology again this year to help keep attention focused on mitochondrial dysfunction as a key safety issue, but also to hear about the latest developments on other fronts.
Dr James Dykens- Associate Research Fellow, Drug Safety R&D, Pfizer